The Council and the Parliament have reached a deal on new rules to make the EU’s pharmaceutical sector fairer and more ...
Highly encouraging early data from the ongoing Phase 1b study evaluating investigational drug GNS561 with a MEK inhibitor (MEKi) in KRAS mutated ...
The past year marked a period of sustained momentum for India’s healthcare and pharmaceutical sector, supported by rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback